chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I found out about my pregnancy the day I got the vaccine (which was after I got the vaccine). After that I proceeded to get a pregnancy test confirmation  (march 26) and it came back positive from the doctors office. On March 28 I began to have bleeding and I passed a blood clot the size of a baseball.  I called the nurse line that next day and they told me they could not give me any medical advice because I had not been seen by a doctor for this pregnancy.  During that week I began to experience a rash that began in the middle of my chest and proceeded to spread All over my stomach and back. It is now April 19 in the rash has continue to spread all over my limbs. On April 5 I went to the pregnancy clinic and was also getting a ultrasound and they were unable to locate the embryo in the uterus. On April 15 I got an ultrasound transvaginal and they were unable to locate an embryo or in a heartbeat. I then went to the hospital the next day on April 16 the hospital that I received my vaccine at and they did not give me any care and told me that my rash was a possible contact to something I may have come in contact recently. I try to express to the doctor that I?ve been experiencing issues since I received the vaccine and he did not connect any of the dots to my experiences.  As of today April 19 I have come across several Different websites that state that red spot is a part of the symptoms an adverse reaction to the vaccine or should be of concern.
I had zero reaction. Two days later I work up with a red swollen rash, almost bruised looking. Its a little irritated
Janssen COVID-19 Vaccine EUA Patient presented to ED on 4/2/2021 with complaints of "worst headache of my life", waking her up at 2 am on 4/1/202. Describes the headache as being 10/10, sharp, and located at the back of her head. Associated fevers of 101.2F, chills, generalized weakness and dizziness. The patient states she took ibuprofen with mild improvement of her symptoms, so called her PCP and had a CT head done. The patient states she received a call from her PCP prior to arrival stating to go to the closest emergency department because her CT head showed an acute cerebellar hemorrhage. Patient admitted to Medical Center. Cerebral angio performed on 4/5/2021 which demonstrated dural sinus thrombus. Platelet count 255 on 4/2/2021 (Range 193 - 255 from April 5th through April 14th).
Pt recvd Recombivax B #3 approx 10 min p/inject c/o feeling funny, head swimming & heaviness in chest; Then fell to floor & LOC for about 1 min; When conscious was hyperventilating & very anxious; Taken to ER;
Arm pain with the previous 3 doses/Arm hurt; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm pain with the previous 3 doses/Arm hurt) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes.   On 31-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Sep-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm pain with the previous 3 doses/Arm hurt). At the time of the report, PAIN IN EXTREMITY (Arm pain with the previous 3 doses/Arm hurt) had resolved.            Concomitant product information was not provided. Treatment information was not provided.   This case was linked to MOD-2022-525546, MOD-2022-525602, MOD-2022-525616 (Patient Link).
No ADR, timing ERROR 2nd dose given 49 days after 1st Narrative: No ADR, timing ERROR, 2nd dose given 49 days after 1st
High fever (105 degrees), malaise, arthritis, swollen lips, hives, difficulty sleeping, muscle weakness, exhaustion, swollen tongue. All x 2 days. Intermittent arthralgia, malaise, hives, muscular weakness.
Sore arm; Tired; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (Sore arm) and FATIGUE (Tired) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse reaction.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE PAIN (Sore arm) and FATIGUE (Tired). At the time of the report, INJECTION SITE PAIN (Sore arm) and FATIGUE (Tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       This case was linked to MOD-2021-068118 (Patient Link).   Reporter did not allow further contact
Parents describe at about 9 PM day of 4-month immunization, pt had twitching of extremities, eyes rolled back slightly and made little gasping noises. Episode resolved in approx 1 minute. He cried after event and then his head appeared weak and he was sleepy. Taken to ER for evaluation. No further events.
17y/o female brought in for a well-adolescent visit was given Pfizer Covid vaccine(gray cap). Per a reporter, member given monovalent, the order stated bivalent.  The parent, manager, and physician were notified of the error.
Initial misuse report received from a healthcare professional on 19 March 2013. A 3-year-old patient received IMOVAX that had expired on an unspecified date. No adverse event was reported. List of documents held by sender: none.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Nurse). The reporter is the patient.  A 70-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 19Sep2022 at 16:00 as dose 5 (booster), single (Lot number: GH9703) at the age of 70 years, in right arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient had no relevant medical history. The patient had no known allergy. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19 including Paxlovid from 14Mar2023.; Sender's Comments: Considering a plausible drug-event temporal association, a reasonable possibility that the events drug ineffective and Covid-19 are related to BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5) cannot be excluded.  This case will be reassessed should additional information become available.
19AUG92 noted reddened hard lump @ site of DTP-called clinic went in & was noted appearance of abscess; pt taken to hosp ER & given ATB; dx sterile abcess;
(1) Sudden onset of severe headache that lasted 72 hrs. (2) Eye irritation (burning and redness). (3) Hives and red streaks on legs. (4) Nausea. (5) Weakness/paleness.
Temperature excursions during a period of 33 weeks on 2021/The vial was put into cooler, sometimes there was a period 1hr or 1.5hr approximately, when temperature data logger registered 34 or 35; Dose administered after 1 temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Temperature excursions during a period of 33 weeks on 2021/The vial was put into cooler, sometimes there was a period 1hr or 1.5hr approximately, when temperature data logger registered 34 or 35) and POOR QUALITY PRODUCT ADMINISTERED (Dose administered after 1 temperature excursion) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Jan-2021 at 1:36 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 11-Jan-2021, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Dose administered after 1 temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Temperature excursions during a period of 33 weeks on 2021/The vial was put into cooler, sometimes there was a period 1hr or 1.5hr approximately, when temperature data logger registered 34 or 35). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Temperature excursions during a period of 33 weeks on 2021/The vial was put into cooler, sometimes there was a period 1hr or 1.5hr approximately, when temperature data logger registered 34 or 35) and POOR QUALITY PRODUCT ADMINISTERED (Dose administered after 1 temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The patient age was reported as 72.48. No concomitant medications were reported. On 11-Jan-2021, Excursion time was 2 PM, temp was 35, condition of vaccine prior to vaccination was not frozen, vaccine was moved to fridge on 08-Jan-2021, vial was moved to clinic on 11-Jan-2021, 9 vial was moved to clinic. Vaccine BUD date was 07-Feb-2021. The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic. The patient experienced more than 1 temperature excursion during 33 weeks on 2021. In general, HCP explained each time a vial was put into a cooler, sometimes there was a period of time of 1 hour or 1 hour and a half approximately, when temperature data logger registered 34 or 35 degree Fahrenheit. On 11-Jan-2021, the temperature recorded was 35 degree Fahrenheit that has been reached by the vial. Temperature recordings were took by using a traceable temperature monitor at every hour. The vial was not in a frozen state at the time of vaccine administration. After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature. No treatment information was provided.   This case was linked to MOD-2022-566976 (Patient Link).
Headache, Myalgia & Fever Narrative: Per nursing report: "received COVID injection on 1/26/21 and is now experiencing fever, muscle spasm, headache."
3 months after the vaccine on June 6th 2022 the left eye started having similar symptoms my right eye had a year earlier - migraine ora, eye pain, slivers of flashing light on outer left side of my eye, and strands and spiderwebs in my field of vision with a black dot.  I also had a allergic reaction to the vaccine, my nose, eyes, lips inside of my ears --- everything started to itch My checks started to turn red and my bottom lip and my eye was itchy and started swelling and that's a sign for me that i'm having an allergic reaction.  this didn't have that with the pfizer
Covid Arm - 8 days after injection. Reaction: round, red, raised, hard bump, at injection site. No other side effects at this time.
Systemic: Dizziness / Lightheadness-Mild, Systemic: Fainting / Unresponsive-Mild, Additional Details: Patient got the vaccine around 12:17pm by RN. After 3 mins, patient called the nurse and states he wasn't feeling well and passed out for about 1 min. Woke up sweting and dizzy. he drank a full bottle of water. Blood pressure was taken @12:24pm 147/125, P=105. Patient remained seated for observation. @12:40pm BP=135/84, P=65. Follow up with the patient 10/20/21 and stated he is ok.
Received initial dose of Moderna on 1/29/21 (LOT # 039K20A) and second dose on 2/26/21 (LOT 3 028L20A).  Noticed  ringing in ears (Tinitus) sometime in March.  Went to an audiologist in June and another in August for this because I thought is was odd because of the sudden onset of symptoms, literally overnight.  Both times I was told it's just hearing loss.  Received my booster on  12/29/21 and on 1/14/22 I noticed a significant increase in the ringing in my ears. Only then did I notice the sudden onset of symptoms are approximately 2 weeks after receiving the vaccine.   Now it's very, very  bad.
Nausea; Fatigue; This is a spontaneous report from a non-contactable consumer, the patient. A 28-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE;Lot Number: EW0172) via an unspecified route of administration in the arm left on an unknown date (at the age of 28-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient was allergic to penicillin. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. On an unknown date the patient experienced nausea and fatigue. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcomes of the events nausea and fatigue was unknown at the time of report.  No follow-up attempts are possible. No further information is expected.
Shivering; coughing; headache; nausea; G.I. distress.
3 minutes after receiving the vaccine my mouth dried up, I got very thirsty and like about 10 minutes later I began to feel my heart very accelerated they checked me and I had around 125 palpitations, being that I am always like 70 I drank water and it didn't go down much. They had me there for a while about half an hour and they told me that I could go that I wasn't too bad that if I got chest pain go to the emergency room to the hospital. During the day I have continued with the heartbeat around 100-115 until now that is 7:20 at night (10 hours after vaccination)
Right deltoid pain radiating into neck since vaccination.  Gradual onset of pain - joint movement not affected.  Patient unable to sleep, Tylenol is not providing relief.  Seen in Emergency Center on 24 April 2021 for assessment.  Given Decadron 10 mg PO x1, Toradol 60 mg IM x1.  Discharged with rxs for Naproxen and Flexeril.  Shoulder x-rayed - no evidence of fracture, deformities or dislocation. Patient f/u on 28 April 2021 - provider ordered MRI, Xray, EMG for assessment
Soreness and warmness of arm.  Chills and febrile x2 days.
9 x 7 cm erythematous, indurated raised oval lesion. Warm to touch, no fever, started with size of a quarter on day of immunization and progressed. Treatment included warm compresses and Benadryl and Tylenol.
approximately 7 days after Vaccine was administered, a full body rash broke out on my child. She began getting abnormally fussy until she was full blown screaming, crying, wining for almost 24 hours. At the pediatricians office, the P.A. informed me her fussiness and full body rash was typical of the MMR and did take up to a week for it to show up, like hers. I assured her that something  was definitely wrong as I held her flailing body, that screamed as if she was in excruciating pain I could not help her with. While we waited for the P.A. to come in, my daughter screamed in agony, (could walk at 10 months) and she threw herself to the floor moving left to right as if her head was in pain, shaking it and throwing it back  as if she could not contain the pain she was experiencing. I assured the P,A. that NONE OF THIS WAS NORMAL. My child was sent home with Tylenol and instructions to monitor her behavior and rash. She screamed herself to sleep hours later. She must have suffered at leas 24 hours with the last 3 hours of those being screaming and throwing herself.
Patient reports itching. Patient was advised to take some diphenhydramine to help with itch.
Pt was CAO x 4 upon EMS arrival. EMS 3 stated pt experienced a syncopal episode after getting her COVID vaccine. Pt had a brief LOC and was initially hypotensive. IV was initiated by EMS 3 and NS was started. VS were WNL upon EMS arrival. Pt skin was still pale and clammy during assessment. Pt stated this has happened in the past with shots and blood draws, however, she has never fully lost consciousness. Pt was still c/o dizziness. Pt requested transport to REX ER. Pt was on the cardiac monitor upon EMS 14 arrival and a sinus rhythm was noted. 12 lead revealed a sinus rhythm with no STEMI criteria met. Pt was able to stand and pivot onto the stretcher without incident. Pt secured via straps and loaded into the unit. Once in the unit, VS reassessed. NS was reduced to a KVO rate due to improvement in BP. Pt had received approx 200mL of NS at the time. Pt denied any chest pain, SOB, N/V, or abd pain. Pt only complaint was dizziness. Pt was initially very anxious and was coached through breathing techniques which improved her anxiety. EMS left en route to REX ER. Pt was monitored during transport with improvement in her condition. Pt skin color and condition improved and her VS remained WNL. Pt denied any complaints during transport other than dizziness which she reported was improving. EMS arrived at REX ER. Pt was taken into the ER triage area and was able to stand and pivot onto a wheel chair. NS DC'd, pt received approx 300mL total. Report given to the triage RN and care transferred to same.
Pt. complained of swelling of tongue and canker sore on bottom of tongue; happened  "a few hours" after receiving the injection; no other facial swelling/airway did not close off per pt; pt took BENADRYL and said symptoms resolved.
"Severe" vomiting for 4 days; low grade fever; fussy and irritable. (Tx: Pedialyte). "Saw dr a couple of times d/t vomiting".
Information has been received from a licensed practical nurse concerning a 14 year old female, who on 13-JAN-2008 was vaccinated with a second dose of Gardasil. On 13-JAN-2008 the patient experienced seizure. The patient was rushed to the emergency room. At the time of the report, the outcome of the patient was unknown. No product quality complaint was involved. Upon internal review seizure was considered to be an other important medical event. Additional information has been requested.
patient woke up filling faint and dizzy. temperature went to 102 and his blood glucose level was 160.
First day developed a headache, and a bad rash on my chest that was very itchy for 2 days, rash was visible for approx. 2 weeks. (took a picture), second day had flu like symptoms, headache turned into a migraine 24 hours after initial headache began.  Had joint pain, slight cough and lower back ache as well as headache until Saturday morning 3/13/2021.  Took Tylenol at home and got extra rest until all symptoms went away.
Pt described the vaccine as painful at the time of injection as if a nerve had been hit. She developed a small lump and discomfort rapidly. She reported soreness and difficulty using her arm for the two months following the injection.
dizziness; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Mar-2021, the patient experienced DIZZINESS (dizziness). At the time of the report, DIZZINESS (dizziness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided.  Treatment medications was not provided.   Reporter did not allow further contact
Congestion about 2 weeks after administration followed by vomiting, gagging, choking, blood coming from ear, middle ear infection, one episode of completely stopped breathing. Symptoms lasted about a month.
Vaccine administered after temperature excursion/vials were in freezer and refrigerator where temperature dropped to frozen vaccine -13.79 C, refrigerator 12 C; Vaccine administered after temperature excursion/vials were in freezer and refrigerator where temperature dropped to frozen vaccine -13.79 C, refrigerator 12 C; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT STORAGE ERROR (Vaccine administered after temperature excursion/vials were in freezer and refrigerator where temperature dropped to frozen vaccine -13.79 C, refrigerator 12 C) and EXPIRED PRODUCT ADMINISTERED (Vaccine administered after temperature excursion/vials were in freezer and refrigerator where temperature dropped to frozen vaccine -13.79 C, refrigerator 12 C) in a 41-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, the patient experienced PRODUCT STORAGE ERROR (Vaccine administered after temperature excursion/vials were in freezer and refrigerator where temperature dropped to frozen vaccine -13.79 C, refrigerator 12 C) and EXPIRED PRODUCT ADMINISTERED (Vaccine administered after temperature excursion/vials were in freezer and refrigerator where temperature dropped to frozen vaccine -13.79 C, refrigerator 12 C). On 02-Apr-2021, PRODUCT STORAGE ERROR (Vaccine administered after temperature excursion/vials were in freezer and refrigerator where temperature dropped to frozen vaccine -13.79 C, refrigerator 12 C) and EXPIRED PRODUCT ADMINISTERED (Vaccine administered after temperature excursion/vials were in freezer and refrigerator where temperature dropped to frozen vaccine -13.79 C, refrigerator 12 C) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication were reported.  No treatment information was provided.   This case was linked to MOD21-068620 (E2B Linked Report).; Sender's Comments:  MOD21-068620:crosslinked
ACUTE RESPIRATORY FAILURE 6/27/2021 ADULT OBSTRUCTIVE SLEEP APNEA, MILD  RESPIRATORY FAILURE, UNSPECIFIED ACUITY 8/3/2021 ADULT OBSTRUCTIVE SLEEP APNEA, MILD  ACUTE RESPIRATORY FAILURE 6/27/2021 DM 2 W BILAT MODERATE NONPROLIFERATIVE RETINOPATHY W MACULAR EDEMA  RESPIRATORY FAILURE, UNSPECIFIED ACUITY 8/3/2021 DM 2 W BILAT MODERATE NONPROLIFERATIVE RETINOPATHY W MACULAR EDEMA         ACUTE RESPIRATORY FAILURE 6/27/2021 LATE EFFECT OF STROKE  RESPIRATORY FAILURE, UNSPECIFIED ACUITY 8/3/2021 LATE EFFECT OF STROKE
I read they call Covid arm left arm where I got injected it is red swollen feels warm and pain
fever to 104 w/in 12hrs of vax rash w/in 48hrs
Both arms swollen/red at vaccine sites, pt had been scratching so skin was also scabbed. Had a few scabbed sores- possible pox near varicella site.
Information has been received from a licensed visiting nurse (L.V.N.) concerning a 13-month-old female with a slight heart murmur who on 20-NOV-2006 at 10:00 was vaccinated subcutaneously with a 0.5 ml first dose of Varivax (lot# 654524/1042F). Concomitant vaccinations given on 20-NOV-2006 included: a dose of MMR II (lot# 654820/1027F) (MSD), a fourth dose of Prevnar given intramuscularly and a dose of influenza virus vaccine (unspecified). On 30-NOV-2006 at 11:30 the patient experienced a rash with clusters and erythema on her face and under the chin on her right side only. On 04-DEC-2006 she was seen in the physician's office and had small little clusters on her chin, her face and under her ear. The physician diagnosed her with shingles. No laboratory or diagnostic studies were performed. She was treated with calamine and calamine (+) camphor (+) pramoxine hydrochloride (AVEENO lotion). She recovered as of 06-DEC-2006. The VZVID program was offered. No product quality complaint was involved. Additional information has been requested.